Sujal M. Patel, CEO, President, and Secretary at Nautilus Biotechnology, Inc. (NAUT), bought 50,000 shares at $3.96 ($198K) on 2022-05-09, disclosed to the SEC on 2022-05-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NAUT | BUY | 2025-03-21 | $77K | — | Filing → |
| NAUT | BUY | 2024-03-11 | $41K | — | Filing → |
| NAUT | BUY | 2024-03-07 | $154K | — | Filing → |